Which has grown faster, HUMA or MNOV?

Over the past five years, HUMA grew revenue faster — HUMA at a 2.41% CAGR versus MNOV at -25.46%.

How have HUMA and MNOV total returns compared?

Over the past 5 years, HUMA delivered -45.73% and MNOV delivered -13.62% annualized total return. Past performance doesn't predict future results.

Humacyte, Inc. (HUMA) vs MediciNova, Inc. (MNOV)

A side-by-side comparison of Humacyte, Inc. and MediciNova, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

HUMA

Humacyte, Inc.

$85M

$0.50HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT

MNOV

MediciNova, Inc.

$82M

$1.68HealthcareDelayed quote: Oct 6, 2026, 12:08 PM EDT

Total return — HUMA vs MNOV

growth of $100 · dividends reinvested · last 6y

HUMA -94.8% (-39.0%/yr)MNOV -70.3% (-18.3%/yr)MNOV compounded faster over this window

Log scale — wide-divergence pair

HUMA MNOV

HUMA vs MNOV: by the numbers

•HUMA is the larger company ($85M vs $82M market cap).
•Both run net losses; MNOV's is the smaller (-1168.20% vs -4560.82% net margin).
•HUMA grew revenue faster over the past five years (2.41% vs -25.46% CAGR).

Metrics side by side

Valuation

Metric	HUMA	MNOV
P/S ratio	39.89	89.57
P/B ratio	2.71	2.21

Profitability

Metric	HUMA	MNOV
Gross margin	-736.46%	7.58%
Operating margin	-5271.69%	-3242.47%
Net margin	-4560.82%	-1168.20%
ROE	-309.44%	-28.85%
ROIC	-90.27%	-31.62%

Growth (annualized)

Metric	HUMA	MNOV
Revenue CAGR (5Y)	2.41%	-25.46%
Total return CAGR (5Y)	-45.73%	-13.62%

Frequently asked

Which has grown faster, HUMA or MNOV?: Over the past five years, HUMA grew revenue faster — HUMA at a 2.41% CAGR versus MNOV at -25.46%.
How have HUMA and MNOV total returns compared?: Over the past 5 years, HUMA delivered -45.73% and MNOV delivered -13.62% annualized total return. Past performance doesn't predict future results.

Go deeper

Full HUMA analysis Full MNOV analysis Interactive comparison tool

Dig into the metrics

Humacyte ROE MediciNova ROE Humacyte operating margin MediciNova operating margin Humacyte revenue growth MediciNova revenue growth Humacyte free cash flow MediciNova free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.